Evidence map›Paper›PMID 28687674›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Anti-inflammatory ω-3 endocannabinoid epoxides.

Daniel R McDougle, Josephine E Watson, Amr A Abdeen, Reheman Adili, Megan P Caputo, John E Krapf, Rodney W Johnson, Kristopher A Kilian, Michael Holinstat, Aditi Das

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05386862 (Wayne Warrior CAnnabis Research and Education), which is not on this map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05386862 nawithdrawnnot on this mapstarted 2022, after this paper: background citation

Wayne Warrior CAnnabis Research and Education: Naturalistic Observation and Harm Reduction

TypeinterventionalSponsorWayne State UniversityRan2022 to 2024Enrolled0ConditionsPost Traumatic Stress Disorder, Cannabis Use, SuicideArmsReduce THC Use
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. DICER-driven regulation of lipid metabolism and macrophage-adipocyte crosstalk in partial lipodystrophy.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
    Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Daniel R McDougleDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Champaign, IL 61801.
Josephine E WatsonDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Champaign, IL 61801.
Amr A AbdeenDepartment of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Champaign, IL 61801.
Reheman AdiliDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48109.
Megan P CaputoDivision of Nutritional Sciences, University of Illinois at Urbana-Champaign, Champaign, IL 61801.
John E KrapfDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Champaign, IL 61801.
Rodney W JohnsonDivision of Nutritional Sciences, University of Illinois at Urbana-Champaign, Champaign, IL 61801.
Kristopher A KilianDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Champaign IL 61801.
Michael HolinstatDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48109.
Aditi DasDepartment of Comparative Biosciences, University of Illinois at Urbana-Champaign, Champaign, IL 61801; aditidas@illinois.edu.
University of Illinois Urbana-Champaign · USMichigan Medicine · USUniversity of Michigan–Ann Arbor · US

Funding

Role of 12-lipoxygenase in platelet reactivity and type 2 diabetes mellitusR01HL114405 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLINSTAT, MICHAEL ALLAN · 2013 to 2017
$1.9M
Developmental Origins of Decreased ResilienceR01HD069899 · NICHD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI JOHNSON, RODNEY W · 2012 to 2016
$1.9M
Biochemical Mechanism of Eicosanoid Synthesizing EnzymesR01GM115584 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI DAS, ADITI · 2017 to 2022
$1.7M
12-HETrE regulation of plateletsR01GM105671 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLINSTAT, MICHAEL ALLAN · 2013 to 2017
$1.6M
Discovery of omega-3 endocannabinoid epoxides and elucidation of their neuroinflammatory propertiesR03DA042365 · NIDA · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI DAS, ADITI · 2017 to 2018
$143k
6 · The paper itself

Abstract

Clinical studies suggest that diets rich in ω-3 polyunsaturated fatty acids (PUFAs) provide beneficial anti-inflammatory effects, in part through their conversion to bioactive metabolites. Here we report on the endogenous production of a previously unknown class of ω-3 PUFA-derived lipid metabolites that originate from the crosstalk between endocannabinoid and cytochrome P450 (CYP) epoxygenase metabolic pathways. The ω-3 endocannabinoid epoxides are derived from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to form epoxyeicosatetraenoic acid-ethanolamide (EEQ-EA) and epoxydocosapentaenoic acid-ethanolamide (EDP-EA), respectively. Both EEQ-EAs and EDP-EAs are endogenously present in rat brain and peripheral organs as determined via targeted lipidomics methods. These metabolites were directly produced by direct epoxygenation of the ω-3 endocannabinoids, docosahexanoyl ethanolamide (DHEA) and eicosapentaenoyl ethanolamide (EPEA) by activated BV-2 microglial cells, and by human CYP2J2. Neuroinflammation studies revealed that the terminal epoxides 17,18-EEQ-EA and 19,20-EDP-EA dose-dependently abated proinflammatory IL-6 cytokines while increasing anti-inflammatory IL-10 cytokines, in part through cannabinoid receptor-2 activation. Furthermore the ω-3 endocannabinoid epoxides 17,18-EEQ-EA and 19,20-EDP-EA exerted antiangiogenic effects in human microvascular endothelial cells (HMVEC) and vasodilatory actions on bovine coronary arteries and reciprocally regulated platelet aggregation in washed human platelets. Taken together, the ω-3 endocannabinoid epoxides' physiological effects are mediated through both endocannabinoid and epoxyeicosanoid signaling pathways. In summary, the ω-3 endocannabinoid epoxides are found at concentrations comparable to those of other endocannabinoids and are expected to play critical roles during inflammation in vivo; thus their identification may aid in the development of therapeutics for neuroinflammatory and cerebrovascular diseases.

Indexed as

AmidohydrolasesAnimalsAnti-Inflammatory AgentsBrainCattleCytochrome P-450 CYP2J2Cytochrome P-450 Enzyme SystemDrug Evaluation, PreclinicalEndocannabinoidsEpoxide HydrolasesEpoxy CompoundsEthanolaminesFatty Acid Amide HydrolasesFatty Acids, Omega-3HumansLipid MetabolismAmidohydrolasesAnti-Inflammatory AgentsCYP2J2 protein, humanCytochrome P-450 CYP2J2Cytochrome P-450 Enzyme SystemEndocannabinoidsEpoxide HydrolasesEpoxy CompoundsEthanolaminesFatty Acid Amide HydrolasesFatty Acids, Omega-3cytochrome P450endocannabinoidepoxyeicosatrienoic acidsepoxygenaseneuroinflammation

Identifiers

PMID28687674
PMCPMC5544256
OpenAlexW2728593277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.